New hope for slowing kidney damage in high blood pressure patients
NCT ID NCT07223502
Summary
This study aims to find out which of two different drug combinations works better for people who have both high blood pressure and chronic kidney disease with protein in their urine. Researchers will compare a newer drug called finerenone against a combination pill containing two older medications (torsemide and spironolactone). The goal is to see which treatment better controls blood pressure, reduces kidney stress, and maintains safe potassium levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION (HTN) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sarfez Pharmaceuticals, Inc.
RECRUITINGVienna, Virginia, 22182, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.